Voyageur Pharmaceuticals (CVE:VM) Hits New 1-Year Low – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM) shares hit a new 52-week low on Monday . The company traded as low as C$0.10 and last traded at C$0.10, with a volume of 181400 shares changing hands. The stock had previously closed at C$0.11.

Voyageur Pharmaceuticals Stock Down 9.1%

The company has a market cap of C$17.95 million, a price-to-earnings ratio of -10.00 and a beta of 1.07. The company has a current ratio of 0.18, a quick ratio of 0.84 and a debt-to-equity ratio of 6.05. The business has a fifty day moving average price of C$0.13 and a two-hundred day moving average price of C$0.15.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.